Annual Current Liabilities
$2.39 M
-$3.05 M-56.08%
December 31, 2023
Summary
- As of February 12, 2025, SPRY annual total current liabilities is $2.39 million, with the most recent change of -$3.05 million (-56.08%) on December 31, 2023.
- During the last 3 years, SPRY annual current liabilities has fallen by -$5.82 million (-70.88%).
- SPRY annual current liabilities is now -70.88% below its all-time high of $8.21 million, reached on December 1, 2020.
Performance
SPRY Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$16.62 M
+$9.90 M+147.18%
September 30, 2024
Summary
- As of February 12, 2025, SPRY quarterly total current liabilities is $16.62 million, with the most recent change of +$9.90 million (+147.18%) on September 30, 2024.
- Over the past year, SPRY quarterly current liabilities has increased by +$9.90 million (+147.18%).
- SPRY quarterly current liabilities is now at all-time high.
Performance
SPRY Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SPRY Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.1% | +147.2% |
| 3 y3 years | -70.9% | +147.2% |
| 5 y5 years | -70.9% | +147.2% |
SPRY Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -70.8% | at low | at high | +595.2% |
| 5 y | 5-year | -70.9% | at low | at high | +595.2% |
| alltime | all time | -70.9% | at low | at high | +595.2% |
ARS Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $16.62 M(+147.2%) |
| Jun 2024 | - | $6.72 M(+81.0%) |
| Mar 2024 | - | $3.71 M(+55.4%) |
| Dec 2023 | $2.39 M | $2.39 M(-78.6%) |
| Sep 2023 | - | $11.18 M(+11.2%) |
| Jun 2023 | - | $10.05 M(+2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $9.84 M(+80.7%) |
| Dec 2022 | $5.44 M(-33.5%) | $5.44 M(-27.0%) |
| Jun 2022 | - | $7.46 M(-8.9%) |
| Dec 2021 | $8.19 M(-0.3%) | - |
| Dec 2021 | - | $8.19 M |
| Dec 2020 | $8.21 M | - |
FAQ
- What is ARS Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals annual current liabilities year-on-year change?
- What is ARS Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly current liabilities year-on-year change?
What is ARS Pharmaceuticals annual total current liabilities?
The current annual current liabilities of SPRY is $2.39 M
What is the all time high annual current liabilities for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual total current liabilities is $8.21 M
What is ARS Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, SPRY annual total current liabilities has changed by -$3.05 M (-56.08%)
What is ARS Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of SPRY is $16.62 M
What is the all time high quarterly current liabilities for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly total current liabilities is $16.62 M
What is ARS Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, SPRY quarterly total current liabilities has changed by +$9.90 M (+147.18%)